ABT Income Statement
Abbott Laboratories - Revenue, Expenses & Profit Analysis
Stock Price
$0.00
Market Cap
-
Most Recent Quarter
Period: FY(2024-12-31)
Revenue
Total sales from operations
$41.95B
+0.0% YoY
Cost of Revenue
Direct costs of sales
$18.71B
Gross Profit
Revenue - Cost of Revenue
$23.24B
Operating Income
Gross Profit - Operating Expenses
$6.83B
Net Income
Bottom line profit
$13.40B
Earnings Per Share (Diluted)
Net income per share
$7.64
Profitability Metrics
Historical Income Statements
| Period | Revenue | Gross Profit | Operating Income | Net Income | EPS |
|---|---|---|---|---|---|
| FY | $41.95B | $23.24B | $6.83B | $13.40B | $7.64 |
| 2024-12-31 | $41.95B | - | - | $13.40B | $7.64 |
| FY | $40.11B | $22.13B | $6.48B | $5.72B | $3.26 |
| 2023-12-31 | $40.11B | - | - | $5.72B | $3.26 |
| FY | $43.65B | $24.51B | $8.36B | $6.93B | $3.91 |
View Complete Financial Analysis
Full income statements, balance sheets, cash flows, and AI-powered insights
Open Full AnalysisFrequently Asked Questions
What is ABT's revenue?
ABT's most recent quarterly revenue was $41.95B, representing a growth of 0.0% year-over-year.
Is ABT profitable?
ABT reported a profit of $13.40B in the most recent quarter.
What is ABT's operating income?
ABT's operating income was $6.83B in the most recent quarter.
What is ABT's earnings per share (EPS)?
ABT reported diluted earnings per share of $7.64 in the most recent quarter.
What is ABT's gross profit margin?
Gross margin data is available in the profitability metrics section.